KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Interest Coverage Ratio (2019 - 2025)

Esperion Therapeutics' Interest Coverage Ratio history spans 7 years, with the latest figure at 3.77 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 2200.52% year-over-year to 3.77; the TTM value through Dec 2025 reached 0.71, down 11.62%, while the annual FY2025 figure was 0.71, 22.41% down from the prior year.
  • Interest Coverage Ratio reached 3.77 in Q4 2025 per ESPR's latest filing, up from 0.45 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 5.15 in Q1 2024 to a low of 10.19 in Q1 2021.
  • Average Interest Coverage Ratio over 5 years is 1.9, with a median of 2.68 recorded in 2023.
  • The largest YoY upside for Interest Coverage Ratio was 2200.52% in 2025 against a maximum downside of 122.07% in 2025.
  • A 5-year view of Interest Coverage Ratio shows it stood at 4.14 in 2021, then increased by 28.37% to 2.97 in 2022, then grew by 5.16% to 2.81 in 2023, then surged by 93.63% to 0.18 in 2024, then soared by 2200.52% to 3.77 in 2025.
  • Per Business Quant, the three most recent readings for ESPR's Interest Coverage Ratio are 3.77 (Q4 2025), 0.45 (Q3 2025), and 0.35 (Q2 2025).